Drug Trial Radar · NCT06309966
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Last checked: Nov 20, 2026Latest source record: Aug 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
390
Planned (sponsor's estimate)
Start
May 13, 2024
Primary completion
Oct 2026
Study completion Oct 2026
Sponsor
- Lead sponsor
- Biohaven Therapeutics Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 13, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
Conditions
- Focal Epilepsy
Interventions
BHV-7000Drug
BHV-7000 50 mg. Participants will take blinded investigational product (IP) once daily
BHV-7000Drug
BHV-7000 75 mg. Participants will take blinded investigational product (IP) once daily
PlaceboDrug
Matching placebo taken once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in 28-day average seizure frequencyTime frame: Baseline, Week 8 to Week 16
Locations
150 sites in 16 countries. Site status is shown where the registry gives one.
Onyx Clinical Trials
Peoria, Arizona
Xenoscience, Inc.
Phoenix, Arizona
University of Arizona / Banner University Medical Center Phoenix
Phoenix, Arizona
ARENSIA Exploratory Medicine
Phoenix, Arizona
Clinical Trials, Inc.
Little Rock, Arkansas
Tri Valley Neurology Medical Associates, Inc.
Mission Hills, California
Profound Research LLC
Poway, California
UConn Health
Farmington, Connecticut
Nova Clinical Research, LLC
Bradenton, Florida
Las Mercedes Medical Research
Hialeah, Florida
Coral Clinic Research
Homestead, Florida
Y&L Advance Health Care, Inc d/b/a Elite Clinical Research
Miami, Florida
Serenity Research Center
Miami, Florida
Research Institute of Orlando
Orlando, Florida
Comprehensive Neurology Clinic
Orlando, Florida
Panhandle Research & Medical Clinic
Pensacola, Florida
Knight Neurology
Rockledge, Florida
Encore Medical Research of Weston LLC.
Weston, Florida
Accelerated Clinical Trials, LLC
Peachtree Corners, Georgia
Bluegrass Epilepsy Research
Lexington, Kentucky
DelRicht Research
Baton Rouge, Louisiana
Neurocare Of Louisiana
Covington, Louisiana
University Medical Center New Orleans
New Orleans, Louisiana
DelRicht Research
New Orleans, Louisiana
LSU Health Shreveport
Shreveport, Louisiana
Johns Hopkins University
Baltimore, Maryland
Boston Clinical Trials
Boston, Massachusetts
Boston Neuro Research
South Dartmouth, Massachusetts
SRI International
Plymouth, Michigan
University of Missouri Health Care
Columbia, Missouri
Somnos Clinical Research
Lincoln, Nebraska
NEREG
Hackensack, New Jersey
Tekton Research
Marlboro, New Jersey
Dent Neurosciences Research Center
Amherst, New York
Northwell Health
Great Neck, New York
NYU Langone Health
New York, New York
Montefiore Medical Center
The Bronx, New York
Premier Health
Dayton, Ohio
Oregon Neurology Associates
Springfield, Oregon
AHN
Pittsburgh, Pennsylvania
Showing 40 of 150 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.